Cytisine and E-cigarettes With Supportive Text-messaging for Smoking Cessation (Cess@Tion)
Status:
Not yet recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
This research focuses on maximizing the benefits of proven smoking cessation interventions to
support people who smoke to quit, as part of the strategy to help New Zealand become
smoke-free. A large, pragmatic community-based clinical trial is planned which draws on 15
years of smoking cessation research undertaken by the study team. This research has shown
that both cytisine and nicotine e-cigarettes are more effective than nicotine replacement
therapy at helping people to quit smoking, and are more acceptable to users. New Zealand
research has also shown that text-messages offering advice and support around quitting
smoking are highly effective and acceptable. The planned trial will test whether using
cytisine and nicotine e-cigarettes together will help more New Zealanders to quit smoking
long-term, compared to using cytisine alone or nicotine e-cigarettes alone. Participants in
all three groups will also receive smoking cessation text-messaging behavioral support.